Patrick Malloy serves as Co-Director, National Tax Practice and Strategy with Crescent Grove Advisors, a boutique wealth ...

The Trump administration has made the future of federal funding for cancer research uncertain. At one groundbreaking breast ...

A year's worth of our rigorous lab-testing scores plus your top brand recommendations come together to create our definitive ...

The overwhelming amount of data collected from each basketball game presents teams with a challenge — and an opportunity. Ken Pomeroy and Evan Miyakawa are two of the leaders spearheading a drive to ...

Empower BP is a landmark global pivotal study evaluating the safety and effectivenessof the implantable ARC-IM® Systemto address blood pressure ...

Secure your MCP deployments with zero-trust architecture. Learn about post-quantum encryption, context-aware access, and threat detection for distributed AI.

Across the United States, the future of federal funding for cancer research is uncertain. President Donald Trump has proposed cutting the NIH budget by nearly 40% in the 2026 fiscal year.

Listen and subscribe to Morningstar’s The Long View from your mobile device: Apple Podcasts | Spotify Our guest on the ...

BlockDAG launch date countdown begins as BDAG airdrop claim details and major exchange names emerge. Will final private round ...

In the end, the battle for fashion’s soul turned out to be a battle for the future of business itself.

Amid NIH funding delays, reversals and uncertainty, a scientist at Harvard who studies breast cancer has lost one-third of ...